Pfizer (PFE) Director Ronald E. Blaylock Buys 39,231 Shares

What Happened Ronald E. Blaylock, a director of Pfizer Inc. (PFE), acquired 39,231 shares in an open-market purchase on August 5, 2026. The shares were bought at $25.46 per share for a total transaction value of $998,821. This was an outright purchase (transaction code P), which investors often view as a more bullish signal than a sale.

Key Details

• Transaction date and filing date: 2026-08-05 (filed the same day)
• Transaction type: Open-market purchase (Code P)
• Shares purchased: 39,231 at $25.46 per share
• Total value: $998,821
• Shares owned after transaction: Not specified in the provided filing excerpt
• Footnotes / plans: No 10b5-1 plan or other footnotes were disclosed in the provided details
• Timeliness: No late filing flag indicated (filed on the transaction date)

Context Insider purchases can signal confidence by company insiders but do not prove future stock performance; consider this trade alongside other insider activity, company fundamentals, and market conditions. This filing shows a single open-market buy by a director and appears to have been filed promptly.